Fig. 5From: USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3USP9X promotes the deubiquitination of EGLN3. A, B RBE cells stably expressing shNC, shUSP9X #1 and shUSP9X #2 were subjected to analyze by immunoblotting using indicated antibody. C, D RBE cells added with DMSO or WP1130 were subjected to analyze by immunoblotting using indicated antibody. E, F RBE cells stably expressing pCDH and Flag-USP9X were subjected to analyze by immunoblotting using indicated antibody. G RBE cells stably expressing shNC and shUSP9X were subjected to IP and immunoblotting analysis with the indicated antibodies after 48 h of transfection. Cells were treated with 20 μM MG-132 for 6 h before harvest. H RBE cells were transiently transfected with pCDH and HA-USP9X. IP and immunoblotting analysis were performed with the indicated antibodies after 48 h of transfection. Cells were treated with 20 μM MG-132 for 6 h before harvest. I HEK293T cells were transiently transfected with pCDH, Flag- USP9X and V5-Ubiqutin alone or in combination. IP and immunoblotting analysis were performed with the indicated antibodies after 48 h of transfection. Cells were treated with 20 μM MG-132 for 6 h before harvestBack to article page